Logo of Invex Therapeutics (ASX:IXC)Latest Invex Therapeutics (ASX:IXC) News

Page 3
Page 3 of 3

Invex Therapeutics Cuts Losses Sharply, Advances Alzheimer’s Drug Research

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.
Victor Sage
7 Feb 2025

Invex Therapeutics Unveils Promising Alzheimer's Data from Exenatide Collaboration

Invex Therapeutics reports encouraging results from its collaboration with Tessara Therapeutics, showing Exenatide’s potential to improve neuronal survival in a 3D human brain model of Alzheimer's disease. The company maintains a stable cash position while exploring new neurological partnerships.
Victor Sage
22 Jan 2025